Andrew P. Rasdal serves as Executive at DEXCOM INC, where they oversee executive responsibilities. Since joining the company, Andrew P. Rasdal has executed 8 insider transactions totaling $3.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 6, 2019 involved purchasing 12,500 shares valued at $50.0K.
Andrew P. Rasdal currently holds 77,892 shares of DEXCOM INC (DXCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew P. Rasdal has been a net seller of DXCM stock. They have purchased $50.0K and sold $3.0M worth of shares.
Andrew P. Rasdal's most recent insider trade was on Aug 6, 2019, when they purchased 12,500 shares at $4.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 23, 2018 | OBLN | $200.0K | Award | 109,890 | $1.82 | Discretionary |
| Apr 30, 2018 | OBLN | $9.8K | Award | 2,987 | $3.27 | Discretionary |
| Oct 31, 2017 | OBLN | $5.8K | Award | 808 | $7.17 | Discretionary |
| Apr 30, 2017 | OBLN | $25.0K | Award | 2,768 | $9.03 | Discretionary |
| May 2, 2006 | DXCM | $37.5K | Option Exercise | 125,000 | $0.30 | Discretionary |
| May 2, 2006 | DXCM | $3.0M | Sale | 125,000 | $24.00 | Discretionary |